NIH

green traffic light
December 3, 2015

Microtubules act as cellular ‘rheostat’ to control insulin secretion

Microtubules — cellular “highways” that deliver cargo to the cell membrane for secretion — have a surprising role in pancreatic beta cells. Instead of facilitating glucose-stimulated insulin secretion, they limit it, a team of Vanderbilt investigators reported recently in Developmental Cell.

By Leigh MacMillan
December 3, 2015

Kenworthy to chair NIH biochemistry study section

Anne Kenworthy, Ph.D., professor of Molecular Physiology and Biophysics, has been named to a two-year term as chair of the Biochemistry and Biophysics of Membranes Study Section in the Center for Scientific Review of the National Institutes of Health (NIH).

By Bill Snyder
December 3, 2015

Caucus explores crucial role of NIH research funding

James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, and Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), recently participated in a U.S. Senate National Institutes of Health (NIH) caucus briefing held in Washington, D.C., by Senate NIH caucus co-chairs Sens. Lindsey Graham (R-SC) and Dick Durbin (D-IL).

By John Howser
Image of pain pills (iStock Photo)
November 19, 2015

Study links opioids, infection risk for patients with rheumatoid arthritis

Use of opioid analgesics is associated with an increased risk of hospitalization for serious infections among patients with rheumatoid arthritis, according to a Vanderbilt study published in Arthritis & Rheumatology.

By VUMC News and Communications
Insulin in vials
November 18, 2015

Fighting type 2 diabetes with FGF1

The growth factor FGF1 induces the growth of new insulin-producing beta cells and may help treat type 2 diabetes.

By VUMC News and Communications
November 16, 2015

Children, heart disease, and IQ

Treatment for congenital heart disease during infancy may result in cognitive and attentional deficits during adolescence and young adulthood, Vanderbilt researchers have found.

By VUMC News and Communications
November 12, 2015

Immune system a must for kidney repair

A signaling protein that is essential for recovery from acute kidney injury works by increasing the population of tissue-repairing immune cells.
By Lorena Infante
November 12, 2015

Study helps clarify components of DNA ‘copy machine’

Vanderbilt investigators have generated a “parts list” for the molecular machinery that duplicates DNA each time a cell divides. The research has implications for cancer therapies that target components of this machinery.
By Leigh MacMillan
November 5, 2015

Study further links immune response, serotonin signaling

Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.
By Bill Snyder
November 4, 2015

Detect and defend against pathogens

Understanding factors, such as the receptor TLR9, that detect and defend against pathogens may lead to therapeutic approaches that promote an effective immune response to treat infections.
By Leigh MacMillan
November 3, 2015

VUMC receives NIH grant to develop artificial kidney

The National Institutes of Health has awarded a four-year, $6 million grant to investigators at Vanderbilt University Medical Center (VUMC) and the University of California at San Francisco (UCSF) to develop an implantable artificial kidney.
By Paul Govern
October 30, 2015

Prenatal folic acid and asthma

The timing of folic acid-containing prescription filling during pregnancy was associated with childhood asthma, according to a new Vanderbilt study.
By Leigh MacMillan
October 29, 2015

Inflammation, obesity and diabetes

Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.
By Leigh MacMillan
1 … 59 60 61 62 63 … 101